methylprednisolone hemisuccinate has been researched along with Hemangioma Thrombocytopenia Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chauhan, A; Craver, R; Downing, A; Lotterman, C; Warrier, R | 1 |
1 other study(ies) available for methylprednisolone hemisuccinate and Hemangioma Thrombocytopenia Syndrome
| Article | Year |
|---|---|
Giant vascular malformation with thrombocytopenia in a newborn.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Arm; Female; Hemangioendothelioma; Humans; Hypertrophy; Infant, Newborn; Kasabach-Merritt Syndrome; Magnetic Resonance Imaging; Methylprednisolone Hemisuccinate; Prednisolone; Sarcoma, Kaposi; Vascular Malformations; Vincristine | 2013 |